The Fastest-Growing
PROFESSIONAL SKINCARE BRAND
IN THE UNITED STATES.
2023 Kline Professional Skincare: United States Market Analysis and Opportunities.
Prior to establishing skinbetter science, our Founders developed and honed this biotech-based aesthetic philosophy throughout decades of experience founding and building Medicis Pharmaceutical Corporation from 1998-20121 into one of the leading specialty pharmaceutical companies in the world in both medical dermatology and aesthetic medicine – with signature accomplishments including the launch in the US and Canada of multiple iconic drugs, devices, and biologics such as Restylane®, Dysport®, and Solodyn®.
At skinbetter science, our leadership’s rich heritage in dermatologic and aesthetic medicine informs our entire approach to identifying unmet skincare needs in the market, discovering and developing breakthrough technologies to address those needs, and researching and testing these breakthroughs to the highest standards of clinical and scientific validation. This commitment to advancing patient care through the study of skincare science remains at the core of our brand as we proudly move forward together as a member of the L’Oréal Dermatological Beauty family.
skinbetter science products are available only through our ever-growing network of authorized aesthetic professionals. The broad reach of these clinical practices, together with their ability to deploy our unique better connect business model, enables the optimized availability of our best-in-class skincare products to patients and consumers across North America and, increasingly, the world. We’re not just another skincare company. We deliver exclusively to our authorized physicians and healthcare providers the ability to elevate real-life skincare results for their patients and associated consumers.
1In 2012, our founders negotiated and oversaw the sale of Medicis Pharmaceutical Corporation (formerly NYSE:MRX) to Valeant Pharmaceutical International, now Bausch Health Companies, Inc. (NYSE:BHC). According to the US Patent and Trademark Office, as of October 1, 2023, the SOLODYN® trademark belongs to Medicis Pharmaceutical Corporation, and the RESTYLANE® and DYSPORT® trademarks belong to Galderma Holding S.A. Société Anonyme and Ipsen Biopharm Limited Company, respectively. No reference to the historical development of any products associated with these trademarks herein is intended to suggest any current or prospective ownership, license, or other right concerning such trademarks or to suggest any other type of affiliation, endorsement, or association between skinbetter science, its affiliates, or any of its or their management, directors, owners, or employees and any current owner of these trademarks or any affiliate thereof.
